tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BNTX Stock Latest News

BioNTech’s Cancer Therapy Study Withdrawn: Implications for Investors
Company AnnouncementsBioNTech’s Cancer Therapy Study Withdrawn: Implications for Investors
24h ago
BNTX
BioNTech’s BNT151 Study Update: Early Termination and Market Implications
PremiumCompany Announcements
BioNTech’s BNT151 Study Update: Early Termination and Market Implications
24h ago
BNTX
BioNTech’s Latest Clinical Trial: A New Hope for NSCLC Treatment?
PremiumCompany Announcements
BioNTech’s Latest Clinical Trial: A New Hope for NSCLC Treatment?
24h ago
BNTX
Biontech SE’s BNT317 Study: A New Hope for Advanced Solid Tumors
PremiumCompany Announcements
Biontech SE’s BNT317 Study: A New Hope for Advanced Solid Tumors
2d ago
BNTX
Pfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to Know
PremiumCompany Announcements
Pfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to Know
6d ago
PFE
BNTX
BioNTech SE’s Promising Study on Pancreatic Cancer Treatment: What Investors Need to Know
PremiumCompany AnnouncementsBioNTech SE’s Promising Study on Pancreatic Cancer Treatment: What Investors Need to Know
7d ago
BNTX
BioNTech’s BNT327 Clinical Trial: A New Hope for Small-Cell Lung Cancer?
Premium
Company Announcements
BioNTech’s BNT327 Clinical Trial: A New Hope for Small-Cell Lung Cancer?
7d ago
BNTX
BioNTech’s Promising Phase II Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
BioNTech’s Promising Phase II Study: A Potential Game-Changer in Cancer Treatment
7d ago
BNTX
Pfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to Know
PremiumCompany Announcements
Pfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to Know
8d ago
PFE
BNTX
BioNTech SE: Orphan Drug Designation and Valuation Support Buy Rating
PremiumRatings
BioNTech SE: Orphan Drug Designation and Valuation Support Buy Rating
8d ago
BNTX
BioNTech’s Latest Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
BioNTech’s Latest Study: A Potential Game-Changer in Cancer Treatment?
9d ago
BNTX
BioNTech’s BNT327: A Promising Phase II Trial for Small-Cell Lung Cancer
PremiumCompany Announcements
BioNTech’s BNT327: A Promising Phase II Trial for Small-Cell Lung Cancer
9d ago
BNTX
PremiumCompany AnnouncementsBioNTech’s Latest Clinical Study: A New Frontier in Pancreatic Cancer Treatment
9d ago
BNTX
Kennedy considers review of aluminum in vaccines, Bloomberg says
Premium
The Fly
Kennedy considers review of aluminum in vaccines, Bloomberg says
15d ago
GSK
PFE
BioNTech SE Updates Articles of Association to Boost Financial Flexibility
Premium
Company Announcements
BioNTech SE Updates Articles of Association to Boost Financial Flexibility
16d ago
6K
BNTX
BioNTech SE Announces Acquisition of CureVac N.V.
PremiumCompany Announcements
BioNTech SE Announces Acquisition of CureVac N.V.
16d ago
6K
BNTX
BioNTech price target lowered to $138 from $145 at H.C. Wainwright
PremiumThe Fly
BioNTech price target lowered to $138 from $145 at H.C. Wainwright
17d ago
BNTX
BioNTech SE’s Strategic Acquisition of CureVac Bolsters mRNA Therapeutics and Growth Potential
PremiumRatings
BioNTech SE’s Strategic Acquisition of CureVac Bolsters mRNA Therapeutics and Growth Potential
20d ago
BNTX
BioNTech’s Strategic Acquisition of CureVac: Enhancing mRNA Platform and Market Position
PremiumRatings
BioNTech’s Strategic Acquisition of CureVac: Enhancing mRNA Platform and Market Position
20d ago
BNTX
Strategic Acquisition and Pipeline Synergies Drive Buy Rating for BioNTech
PremiumRatingsStrategic Acquisition and Pipeline Synergies Drive Buy Rating for BioNTech
20d ago
BNTX
BioNTech’s Strategic Acquisition of CureVac: Enhancing Oncology Focus and Expanding mRNA Portfolio
Premium
Ratings
BioNTech’s Strategic Acquisition of CureVac: Enhancing Oncology Focus and Expanding mRNA Portfolio
20d ago
BNTX
BioNTech Announces Strategic Acquisition of CureVac
Premium
Company Announcements
BioNTech Announces Strategic Acquisition of CureVac
21d ago
6K
BNTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >